Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Osteoporos Int. 2018 Oct 10;30(2):323–331. doi: 10.1007/s00198-018-4716-1

Table 1:

Baseline characteristics of cases and controls (mean ± SD, or n, %).

Any Incident VF Incident Moderate/Severe VF
Control (n=62) Case (n=26) p Value Control (n=46) Case (n=20) p Value
Men 36 (58) 13 (50) - 27 (59) 10 (50) -
Women 26 (42) 13 (50) - 19 (41) 10 (50) -
Age (Years) 66.3 (8.4) 68.1 (9.9) 0.381 66.3 (8.9) 68.2 (10.4) 0.451
Height (cm) 169.8 (9.8) 167.5 (9.2) 0.310 170.1 (9.9) 167.5 (9.5) 0.333
Weight (kg) 83.3 (16.9) 83.1 (18.6) 0.973 83.3 (18.2) 83.4 (20.0) 0.974
BMI 28.9 (6.0) 29.7 (7.0) 0.612 28.8 (6.4) 29.8 (7.6) 0.585
Current smoker (yes/no) 4 (6.5) 5 (19.2) 0.117 2 (4.3) 3 (15) 0.159
Total alcohol intake (oz/wk) 2.4 (3.3) 2.0 (3.1) 0.584 2.4 (3.5) 1.75 (3.4) 0.511
Prevalent VF, any (yes/no) 3 (4.8) 14 (53.9) < 0.001 3 (6.5) 10 (50) < 0.001
Prevalent VF, moderate/severe (yes/no) 1 (1.6) 3 (11.5) 0.076 1 (2.2) 2 (10) 0.216
Vertebral Strength, CT-FEA (N) 8706 (2914) 6552 (2391) 0.001 8843 (3178) 6168 (2076) < 0.001
L3 Trabecular vBMD (mg/cm3) 107.3 (35.3) 86.0 (30.9) 0.009 108.8 (38.8) 84.9 (29.6) 0.017
L3 Integral vBMD (mg/cm3) 200.2 (38.3) 165.9 (33.8) < 0.001 200.3 (42.1) 160.9 (30.6) < 0.001
L3 CT-based aBMD (g/cm2) 1.08 (0.21) 0.97 (0.23) 0.032 1.08 (0.21) 0.92 (0.19) 0.006
L3 CT-based BMC (g) 9.16 (2.57) 7.31 (1.96) < 0.001 9.28 (2.73) 6.95 (1.74) < 0.001